At AdaMystic, we deploy the best generative AI and molecular modeling technologies to build a high-throughput pipeline for early-stage drug discovery with atomistic-scale explainability.
Our team has expertise in a range of technical areas including artificial intelligence, computational chemistry, and drug discovery.
Our approach can be used to generate new aptamer, peptide, and small molecule structures, optimized for docking in solution or in-silico membranes. With advanced molecular dynamics coupled with generative AI, high throughput screening can be performed at the atomistic scale providing deep insight into molecular interactions.